Tillkännagivande • May 12
K+S Aktiengesellschaft to Report Q1, 2027 Results on May 11, 2027 K+S Aktiengesellschaft announced that they will report Q1, 2027 results on May 11, 2027 Tillkännagivande • Apr 03
K+S Aktiengesellschaft, Annual General Meeting, May 12, 2026 K+S Aktiengesellschaft, Annual General Meeting, May 12, 2026, at 10:00 W. Europe Standard Time. Tillkännagivande • Mar 17
K+S Aktiengesellschaft to Report Fiscal Year 2026 Results on Mar 11, 2027 K+S Aktiengesellschaft announced that they will report fiscal year 2026 results at 7:00 AM, Central European Standard Time on Mar 11, 2027 Tillkännagivande • Mar 13
K+S Aktiengesellschaft announces Annual dividend, payable on May 15, 2026 K+S Aktiengesellschaft announced Annual dividend of EUR 0.0700 per share payable on May 15, 2026, ex-date on May 13, 2026 and record date on May 14, 2026. Tillkännagivande • Nov 17
K+S Aktiengesellschaft to Report Q3, 2026 Results on Nov 10, 2026 K+S Aktiengesellschaft announced that they will report Q3, 2026 results at 7:00 AM, Central European Standard Time on Nov 10, 2026 Tillkännagivande • Aug 15
K+S Aktiengesellschaft to Report Q2, 2026 Results on Aug 12, 2026 K+S Aktiengesellschaft announced that they will report Q2, 2026 results on Aug 12, 2026 Tillkännagivande • May 15
K+S Aktiengesellschaft to Report Q1, 2026 Results on May 11, 2026 K+S Aktiengesellschaft announced that they will report Q1, 2026 results on May 11, 2026 Tillkännagivande • Mar 15
K+S Aktiengesellschaft to Report Fiscal Year 2025 Results on Mar 12, 2026 K+S Aktiengesellschaft announced that they will report fiscal year 2025 results on Mar 12, 2026 Tillkännagivande • Nov 15
K+S Aktiengesellschaft to Report Q3, 2025 Results on Nov 11, 2025 K+S Aktiengesellschaft announced that they will report Q3, 2025 results on Nov 11, 2025 Tillkännagivande • Aug 14
K+S Aktiengesellschaft to Report Q2, 2025 Results on Aug 12, 2025 K+S Aktiengesellschaft announced that they will report Q2, 2025 results on Aug 12, 2025 Tillkännagivande • May 14
K+S Aktiengesellschaft to Report Q1, 2025 Results on May 13, 2025 K+S Aktiengesellschaft announced that they will report Q1, 2025 results on May 13, 2025 Declared Dividend • Apr 17
Dividend of €0.70 announced Shareholders will receive a dividend of €0.70. Ex-date: 15th May 2024 Payment date: 17th May 2024 Dividend yield will be 5.0%, which is higher than the industry average of 3.0%. Sustainability & Growth Dividend is covered by both earnings (62% earnings payout ratio) and cash flows (37% cash payout ratio). The dividend has increased by an average of 11% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to decline by 51% over the next 3 years. Since a fall of 31% would increase the payout ratio to a potentially unsustainable range, the dividend may be at risk. Tillkännagivande • Mar 15
K+S Aktiengesellschaft to Report Fiscal Year 2024 Results on Mar 13, 2025 K+S Aktiengesellschaft announced that they will report fiscal year 2024 results on Mar 13, 2025 Reported Earnings • Nov 15
Third quarter 2023 earnings released: €0.25 loss per share (vs €1.48 profit in 3Q 2022) Third quarter 2023 results: €0.25 loss per share (down from €1.48 profit in 3Q 2022). Revenue: €880.8m (down 40% from 3Q 2022). Net loss: €47.6m (down 117% from profit in 3Q 2022). Revenue is expected to fall by 3.5% p.a. on average during the next 3 years compared to a 5.9% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 69% per year but the company’s share price has only increased by 28% per year, which means it is significantly lagging earnings growth. Tillkännagivande • Aug 15
K+S Aktiengesellschaft to Report Q1, 2024 Results on May 13, 2024 K+S Aktiengesellschaft announced that they will report Q1, 2024 results at 7:00 AM, Central European Standard Time on May 13, 2024 Tillkännagivande • Aug 11
K+S Aktiengesellschaft to Report Q2, 2024 Results on Aug 14, 2024 K+S Aktiengesellschaft announced that they will report Q2, 2024 results on Aug 14, 2024 Upcoming Dividend • May 05
Upcoming dividend of €1.00 per share at 5.8% yield Eligible shareholders must have bought the stock before 11 May 2023. Payment date: 15 May 2023. Payout ratio is a comfortable 13% and this is well supported by cash flows. Trailing yield: 5.8%. Within top quartile of British dividend payers (5.8%). Higher than average of industry peers (2.3%). Reported Earnings • Mar 16
Full year 2022 earnings released: EPS: €7.88 (vs €11.35 in FY 2021) Full year 2022 results: EPS: €7.88 (down from €11.35 in FY 2021). Revenue: €5.68b (up 77% from FY 2021). Net income: €1.51b (down 31% from FY 2021). Profit margin: 27% (down from 68% in FY 2021). The decrease in margin was driven by higher expenses. Revenue is expected to decline by 7.2% p.a. on average during the next 3 years, while revenues in the Chemicals industry in the United Kingdom are expected to grow by 2.0%. Over the last 3 years on average, earnings per share has increased by 79% per year but the company’s share price has only increased by 52% per year, which means it is significantly lagging earnings growth. Tillkännagivande • Jan 27
K+S Aktiengesellschaft (XTRA:SDF) agreed to acquire 75% stake in Fertilizer business of Industrial Commodities Holdings (Pty) Ltd (ICH). K+S Aktiengesellschaft (XTRA:SDF) agreed to acquire 75% stake in Fertilizer business of Industrial Commodities Holdings (Pty) Ltd (ICH) on January 26, 2023. The new business will operate under the name Fertiva (Pty) Ltd. The balance of 25% of shares in Fertiva will be held by two former ICH shareholders, who will now be a part of the Fertiva management team. The closing of the transaction remains subject to the fulfillment of a number of conditions, including obtaining required regulatory approvals and is expected to close during the second quarter of 2023. Tillkännagivande • Jan 22
K+S Aktiengesellschaft Appoints Carin-Martina Tröltzsch as Member of the Board of Executive Directors, Effective March 15, 2023 The Supervisory Board of K+S Aktiengesellschaft has appointed Dr. Carin-Martina Tröltzsch as a further member of the Board of Executive Directors of the Company. She will assume her position at K+S on March 15, 2023. Dr. Christian H. Meyer, who was already appointed as the new Chief Financial Officer by the Supervisory Board of the Company in February of last year, will also take up his position on March 15, 2023, and will be responsible for the management and further development of the finance area at K+S. Dr. Burkhard Lohr, Chairman of the Board of Executive Directors, had assumed this role on a transitional basis in recent months. Valuation Update With 7 Day Price Move • Jan 19
Investor sentiment improved over the past week After last week's 16% share price gain to €23.17, the stock trades at a forward P/E ratio of 4x. Average forward P/E is 19x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 153% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €12.96 per share. Tillkännagivande • Nov 13
K+S Aktiengesellschaft to Report Q3, 2022 Results on Nov 14, 2023 K+S Aktiengesellschaft announced that they will report Q3, 2022 results at 7:00 AM, Central European Standard Time on Nov 14, 2023 Reported Earnings • Aug 13
Second quarter 2022 earnings released: EPS: €1.93 (vs €0.78 in 2Q 2021) Second quarter 2022 results: EPS: €1.93 (up from €0.78 in 2Q 2021). Revenue: €1.51b (up 127% from 2Q 2021). Net income: €370.3m (up 147% from 2Q 2021). Profit margin: 25% (up from 23% in 2Q 2021). Over the next year, revenue is forecast to grow 20% compared to a 20% decline forecast for the industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 65% per year but the company’s share price has only increased by 15% per year, which means it is significantly lagging earnings growth. Tillkännagivande • Aug 12
K+S Aktiengesellschaft to Report Q2, 2023 Results on Aug 10, 2023 K+S Aktiengesellschaft announced that they will report Q2, 2023 results on Aug 10, 2023 Reported Earnings • May 13
First quarter 2022 earnings released First quarter 2022 results: Revenue: €1.21b (up 65% from 1Q 2021). Net income: €310.9m (up 44% from 1Q 2021). Profit margin: 26% (down from 29% in 1Q 2021). Over the next year, revenue is forecast to grow 46% compared to a 18% decline forecast for the industry in the United Kingdom. Tillkännagivande • May 12
K+S Aktiengesellschaft to Report Q1, 2023 Results on May 09, 2023 K+S Aktiengesellschaft announced that they will report Q1, 2023 results on May 09, 2023 Upcoming Dividend • May 06
Upcoming dividend of €0.20 per share Eligible shareholders must have bought the stock before 13 May 2022. Payment date: 17 May 2022. Trailing yield: 0.6%. Lower than top quartile of British dividend payers (4.7%). Lower than average of industry peers (2.6%). Valuation Update With 7 Day Price Move • Apr 09
Investor sentiment improved over the past week After last week's 18% share price gain to €32.42, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 19x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 86% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €34.32 per share. Buying Opportunity • Mar 30
Now 24% undervalued Over the last 90 days, the stock is up 74%. The fair value is estimated to be €34.01, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 18% over the last 3 years. Meanwhile, the company has become profitable. For the next 3 years, revenue is forecast to grow by 4.6% per annum. Earnings is forecast to decline by 51% per annum over the same time period. Valuation Update With 7 Day Price Move • Mar 24
Investor sentiment improved over the past week After last week's 15% share price gain to €28.80, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 20x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 82% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €34.24 per share. Reported Earnings • Mar 11
Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat Full year 2021 results: EPS: €11.36 (up from €9.88 loss in FY 2020). Revenue: €3.21b (up 32% from FY 2020). Net income: €2.17b (up €4.06b from FY 2020). Profit margin: 68% (up from net loss in FY 2020). The move to profitability was primarily driven by lower expenses. Revenue exceeded analyst estimates by 2.3%. Over the next year, revenue is forecast to grow 28% compared to a 12% decline forecast for the industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 8% per year whereas the company’s share price has increased by 13% per year. Buying Opportunity • Feb 15
Now 21% undervalued Over the last 90 days, the stock is up 38%. The fair value is estimated to be €25.51, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 24% per annum over the last 3 years. The company has become profitable over the last year. Valuation Update With 7 Day Price Move • Feb 09
Investor sentiment improved over the past week After last week's 17% share price gain to €19.10, the stock trades at a forward P/E ratio of 3x. Average forward P/E is 21x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 19% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €33.57 per share. Valuation Update With 7 Day Price Move • Jan 13
Investor sentiment improved over the past week After last week's 15% share price gain to €17.01, the stock trades at a forward P/E ratio of 3x. Average forward P/E is 24x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 4.8% over the past three years. Reported Earnings • Nov 15
Third quarter 2021 earnings released: EPS €6.64 (vs €10.26 loss in 3Q 2020) Third quarter 2021 results: Revenue: €746.3m (down 9.2% from 3Q 2020). Net income: €1.27b (up €3.23b from 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 43% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings. Reported Earnings • Aug 18
Second quarter 2021 earnings released: EPS €0.78 (vs €0.019 loss in 2Q 2020) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: €664.2m (up 13% from 2Q 2020). Net income: €149.9m (up €153.6m from 2Q 2020). Profit margin: 23% (up from net loss in 2Q 2020). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 102 percentage points per year, which is a significant difference in performance. Reported Earnings • May 14
First quarter 2021 earnings released: EPS €1.13 (vs €0.33 loss in 1Q 2020) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: €733.3m (up 13% from 1Q 2020). Net income: €215.7m (up €278.9m from 1Q 2020). Profit margin: 29% (up from net loss in 1Q 2020). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 107 percentage points per year, which is a significant difference in performance. Is New 90 Day High Low • Jan 21
New 90-day high: €10.06 The company is up 58% from its price of €6.36 on 23 October 2020. The British market is up 15% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 13% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €2.20 per share. Is New 90 Day High Low • Jan 05
New 90-day high: €8.47 The company is up 19% from its price of €7.13 on 07 October 2020. The British market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 12% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €4.55 per share. Is New 90 Day High Low • Dec 01
New 90-day high: €7.84 The company is up 38% from its price of €5.69 on 02 September 2020. The British market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 4.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €2.55 per share.